Securities code: 300009 securities abbreviation: Anhui Anke Biotechnology (Group)Co.Ltd(300009) Announcement No.: 2022-010 Anhui Anhui Anke Biotechnology (Group)Co.Ltd(300009) Engineering (Group) Co., Ltd
Announcement on the resolutions of the 17th (Interim) meeting of the seventh board of directors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
The 17th (temporary) meeting of the seventh board of directors of Anhui Anhui Anke Biotechnology (Group)Co.Ltd(300009) Engineering (Group) Co., Ltd. (hereinafter referred to as "the company") was held at 15:00 on February 7, 2022 in the form of on-site and communication meetings. The notice of the meeting will be delivered by direct mail and telephone on the morning of February 7, 2022. There are 11 directors who should attend the meeting and 11 actual directors. All supervisors and senior managers of the company attend the meeting as nonvoting delegates. The meeting was presided over by Mr. Song Lihua, chairman of the company. The convening and convening procedures of the meeting were in accordance with relevant national laws and regulations and the articles of association. The directors attending the meeting carefully deliberated and formed the following resolutions:
Deliberated and passed the proposal on share repurchase plan of the company
The repurchase amount shall not be less than 40 million yuan and not more than 60 million yuan, and the repurchase price shall not exceed 12 yuan / share. Based on the calculation of the upper limit of the total amount of funds to be repurchased and the upper limit of the price of repurchased shares of 12 yuan / share, it is estimated that the number of shares that can be repurchased is 5 million shares, accounting for 0.3052% of the current total share capital of the company; Based on the calculation of the lower limit of 40 million yuan of total repurchase funds and the upper limit of 12 yuan / share of share repurchase price, it is estimated that the number of shares that can be repurchased is 3333300 shares, accounting for 0.2034% of the current total share capital of the company; The specific number of shares to be repurchased shall be subject to the actual number of shares to be repurchased at the end of the repurchase. The implementation period of share repurchase shall not exceed 6 months from the date when the board of directors deliberates and approves the share repurchase plan.
All directors of the company promise that this share repurchase will not damage the debt performance ability and sustainable operation ability of the listed company.
For details, please refer to cninfo (www.cn. Info. Com. CN.) on the gem information disclosure website designated by the CSRC on the same day Announcement on share repurchase scheme of the company (Announcement No.: 2022-009). The proposal was adopted with 11 affirmative votes, 0 negative votes and 0 abstention. It is hereby announced.
Board of directors of Anhui Anhui Anke Biotechnology (Group)Co.Ltd(300009) Engineering (Group) Co., Ltd. February 7, 2022
